Medicines Company (MDCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -102,670 | -119,172 | 3,686 | 89,957 | -92,464 |
| Depreciation Amortization | 15,003 | 57,224 | 41,909 | 27,356 | 13,643 |
| Income taxes - deferred | N/A | -23 | -1,661 | -1,623 | -867 |
| Accounts receivable | -400 | 30,144 | 24,125 | 3,974 | 9,580 |
| Accounts payable and accrued liabilities | -10,972 | -7,398 | -17,265 | -9,320 | -20,559 |
| Other Working Capital | -47,442 | -40,494 | -66,334 | -61,717 | -42,683 |
| Other Operating Activity | 26,879 | -243,590 | -245,445 | -260,956 | 14,970 |
| Operating Cash Flow | $-119,602 | $-323,309 | $-260,985 | $-212,329 | $-118,380 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,333 | -2,176 | -920 | 171 | N/A |
| Net Acquisitions | N/A | 437,875 | 437,875 | 437,875 | 174,068 |
| Purchase Sale Intangibles | N/A | -10,000 | -10,000 | -10,000 | N/A |
| Other Investing Activity | 0 | -10,000 | -13,660 | -10,012 | -13 |
| Investing Cash Flow | $-1,333 | $425,699 | $423,295 | $428,034 | $174,055 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 502,959 | 502,959 | 502,959 | N/A |
| Debt Repayment | N/A | -357,156 | -357,156 | -357,156 | N/A |
| Common Stock Issued | 24,694 | -54,098 | 27,404 | -70,963 | 5,104 |
| Other Financing Activity | -8,890 | -21,129 | -107,520 | -18,247 | -2,773 |
| Financing Cash Flow | $15,804 | $70,576 | $65,687 | $56,593 | $2,331 |
| Exchange Rate Effect | 16 | -700 | -814 | -1,275 | -983 |
| Beginning Cash Position | 546,867 | 374,601 | 373,173 | 373,173 | 373,173 |
| End Cash Position | 441,752 | 546,867 | 600,356 | 644,196 | 430,196 |
| Net Cash Flow | $-105,115 | $172,266 | $227,183 | $271,023 | $57,023 |
| Free Cash Flow | |||||
| Operating Cash Flow | -119,602 | -323,309 | -260,985 | -212,329 | -118,380 |
| Capital Expenditure | -1,333 | -2,176 | -920 | 171 | 0 |
| Free Cash Flow | -120,935 | -325,485 | -261,905 | -212,158 | -118,380 |